Koninklijke Philips Long-Term Investments 2010-2024 | PHG
Koninklijke Philips long-term investments from 2010 to 2024. Long-term investments can be defined as the aggregate value of debt and or equity investments with maturities or benefits lasting more than one year.
- Koninklijke Philips long-term investments for the quarter ending September 30, 2024 were $0.311B, a 30.19% decline year-over-year.
- Koninklijke Philips long-term investments for 2024 were $0.961B, a 133.03% increase from 2023.
- Koninklijke Philips long-term investments for 2023 were $0.412B, a 27.66% decline from 2022.
- Koninklijke Philips long-term investments for 2022 were $0.57B, a 12.57% increase from 2021.
Koninklijke Philips Annual Long-Term Investments (Millions of US $) |
2024 |
$961 |
2023 |
$412 |
2022 |
$570 |
2021 |
$506 |
2020 |
$274 |
2019 |
$262 |
2018 |
$289 |
2017 |
$185 |
2016 |
$276 |
2015 |
$265 |
2014 |
$209 |
2013 |
$214 |
2012 |
$228 |
2011 |
$283 |
2010 |
$240 |
2009 |
$392 |
Koninklijke Philips Quarterly Long-Term Investments (Millions of US $) |
2024-06-30 |
$311 |
2023-06-30 |
$508 |
2023-03-31 |
|
2022-06-30 |
$679 |
2021-06-30 |
$446 |
2020-06-30 |
$248 |
2019-06-30 |
$283 |
2018-06-30 |
$327 |
2017-06-30 |
$195 |
2016-12-31 |
$276 |
2016-09-30 |
$267 |
2016-06-30 |
$299 |
2016-03-31 |
$276 |
2015-12-31 |
$265 |
2015-09-30 |
$254 |
2015-06-30 |
$248 |
2015-03-31 |
$266 |
2014-12-31 |
$209 |
2014-09-30 |
$210 |
2014-06-30 |
$235 |
2014-03-31 |
$249 |
2013-12-31 |
$214 |
2013-09-30 |
$219 |
2013-06-30 |
$214 |
2013-03-31 |
$232 |
2012-12-31 |
$228 |
2012-09-30 |
$244 |
2012-06-30 |
$261 |
2012-03-31 |
$261 |
2011-12-31 |
$283 |
2011-09-30 |
$279 |
2011-06-30 |
$236 |
2011-03-31 |
$232 |
2010-12-31 |
$240 |
2010-09-30 |
$234 |
2010-06-30 |
$244 |
2010-03-31 |
$229 |
2009-12-31 |
$392 |
2009-09-30 |
$386 |
2009-06-30 |
$334 |
2009-03-31 |
$313 |
Sector |
Industry |
Market Cap |
Revenue |
Medical |
MED PRODUCTS |
$23.480B |
$19.503B |
Koninklijke Philips N.V. is the parent company of the Philips Group. The company realigned its three reporting operations into Diagnosis & Treatment businesses consists of Diagnostic Imaging, Ultrasound, Image-Guided Therapy and Enterprise Diagnostic Informatics businesses. Connected Care business comprises the Monitoring & Analytics, Therapeutic Care, Population Health Management, Sleep & Respiratory Care and Connected Care Informatics businesses. Personal Health business consists of the Oral Healthcare, Mother & Child Care and Personal Care. Other consists of Innovation, Emerging Businesses, IP Royalties, Central costs and Other. Notably, Philips completed the divestiture of Domestic Appliances business.
|